Camden Capital »

Sangamo Biosciences shares owned by Camden Capital

Quarter-by-quarter ownership of Sangamo Biosciences (SGMO) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Sangamo Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Sangamo Biosciences held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sangamo Biosciences by Camden Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6k 15k 0.25

More positions owned by Camden Capital

Citigroup Stock (C)
Micron Technology Stock (MU)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
General Electric Stock (GE)
Onemain Hldgs Stock (OMF)
Nvidia Corp Stock (NVDA)
Ishares Core S&p 500 Etf Etf (IVV)
Morgan Stanley Stock (MS)
New York Cmnty Bancorp Stock (FLG)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Wells Fargo Stock (WFC)
Bk Of America Corp Stock (BAC)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Pnc Finl Svcs Group Stock (PNC)

View all positions for Camden Capital

Top funds holding Sangamo Biosciences

Armistice Capital
Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Two Sigma Investments
Balyasny Asset Management
Geode Capital Management
BlackRock
Susquehanna International
UBS Group
Vanguard Fiduciary Trust
Jacobs Levy Equity Management
Bank of America Corporation
Charles Schwab Investment Management
Luminus Management

View all funds holding Sangamo Biosciences